Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Patterson Companies' (PDCO) fourth-quarter fiscal 2024 results reflect a year-over-year improvement in Dental Consumable sales, offset by lower Dental Equipment sales. Animal health sales improve.

Patterson Companies (PDCO) Q4 Earnings Miss, Sales Rise Y/Y

Patterson Companies' stock surged 11.1% after beating revenue forecasts in Q4 of 2024 fiscal year. Despite recent financial performance decline, management's guidance for 2025 suggests potential for growth. PDCO stock remains attractively priced compared to similar enterprises, offering potential upside.

Patterson Companies: Something To Smile About

Patterson Companies, Inc. (NASDAQ:PDCO ) Q4 2024 Earnings Conference Call June 18, 2024 8:30 AM ET Company Participants John Wright - VP, IR Don Zurbay - President and CEO Kevin Barry - CFO Conference Call Participants Kevin Caliendo - UBS Nathan Rich - Goldman Sachs Elizabeth Anderson - Evercore ISI Allen Lutz - Bank of America Jeffrey Johnson - Robert W. Baird Erin Wright - Morgan Stanley Michael Cherny - Leerink Partners Jonathan Block - Stifel, Nicolaus & Company Jason Bednar - Piper Sandler Operator Thank you for standing by and welcome to the Patterson Companies Fourth Quarter Fiscal 2024 Earnings Conference Call.

Patterson Companies, Inc. (PDCO) Q4 2024 Earnings Call Transcript

The headline numbers for Patterson Cos. (PDCO) give insight into how the company performed in the quarter ended April 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Patterson Cos. (PDCO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Patterson Cos. (PDCO) came out with quarterly earnings of $0.82 per share, missing the Zacks Consensus Estimate of $0.83 per share.

Patterson Cos. (PDCO) Misses Q4 Earnings Estimates

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2024 fourth quarter ended April 27, 2024. "Throughout fiscal 2024, Patterson navigated a challenging market environment while continuing to make progress on our strategic objectives to better position the organization for the future," said Don Zurbay, President and CEO of Patterson Companies. "Our fourth quarter results were driven by strong performances in our dental consu.

Patterson Companies Reports Fiscal 2024 Fourth Quarter and Year End Operating Results

KB Home

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Patterson Companies, KB Home And Other Stocks To Watch This Tuesday

Patterson Companies, Inc. PDCO is set to release fiscal 2024 fourth quarter financial results, before the opening bell on Tuesday.

Top Wall Street Forecasters Revamp Patterson Companies Expectations Ahead Of Q4 Earnings

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Patterson Cos. (PDCO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2024.

Stay Ahead of the Game With Patterson Cos. (PDCO) Q4 Earnings: Wall Street's Insights on Key Metrics

Patterson Companies' (PDCO) fiscal fourth-quarter results are likely to reflect an improvement in both the Dental and Animal Health segments.

What's in Store for Patterson Companies (PDCO) in Q4 Earnings?

Patterson Companies' (PDCO) latest offering is likely to offer customers additional options for their electronic insurance processing and patient billing statement workflow.

Patterson Companies' (PDCO) Launch to Boost Insurance Workflow

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2024 fourth-quarter and year end conference call on Tuesday, June 18, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The fiscal 2024 fourth-quarter earnings conference call replay will be ava.

Patterson Companies Fiscal 2024 Fourth Quarter and Year End Conference Call Scheduled for Tuesday, June 18, 2024

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Analysts Estimate Patterson Cos. (PDCO) to Report a Decline in Earnings: What to Look Out for

Patterson Companies' (PDCO) Patterson CarePay+ is likely to improve overall patient care and streamline practice operations.

Patterson Companies' (PDCO) New Launch to Boost Patient Service

IRVING, Texas--(BUSINESS WIRE)--Wellfit® Technologies, Inc., (Wellfit), a healthcare technology platform that provides streamlined dental financing, discount plans and payment processing, announces its partnership with Patterson Dental, and the launch of the CarePay+ solution, powered by Wellfit. CarePay+ is a comprehensive platform designed to optimize patient care and payment management within dental practices. This innovative offering combines Wellfit's expertise in healthcare SaaS managemen.

Wellfit Technologies Announces Partnership With Patterson Dental and Launch of CarePay+™ Solution

Weave Communications

LOVELAND, Colo.--(BUSINESS WIRE)--Today, Patterson Veterinary Supply, Inc., the companion animal business of Patterson Companies, Inc. (Nasdaq: PDCO), announced the addition of Weave (NYSE: WEAV) and its full suite of client engagement features to its product offering portfolio. Weave, a leading all-in-one software platform for small- and medium-sized human and animal healthcare practices, provides automated staff and client interactions and experiences, from marketing and scheduling communicat.

Patterson Veterinary Keeps Pets (And Pet Owners) Happy With Improved Client Experience

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today announced that it has initiated a search for a new leader for its Dental segment. Tim Rogan, who has served as President of Patterson Dental since 2021, has stepped down from his role, effective immediately, and agreed to serve as an advisor to the Company in the short term to facilitate a smooth transition. The Dental segment will continue to report to Chief Operating Officer, Kevin Pohlman. “Our dental business h.

Patterson Companies Announces Dental Leadership Transition

Abbott Labs

CVS Health

Johnson & Johnson

Pfizer

Thermo Fisher Scientific

UnitedHealth Group

With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access to health-related products and services.

7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape

Shares of Patterson Companies have seen unjustified downside despite solid revenue growth and management's investments in the future of the firm.

Patterson Companies: Smiling Through The Pain

AMN Healthcare Services

Bristol-Myers

Royalty Pharma

Semler Scientific

Voyager Therapeutics

With the market trading near all-time highs, undervalued healthcare stocks offer a compelling opportunity. Fundamentally, the sector could benefit from a rotation in the innovation ecosystem.

The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio

Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.

Reasons to Hold Patterson Companies (PDCO) in Your Portfolio

ST. PAUL, Minn.--(BUSINESS WIRE)--On March 11, 2024, the Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) approved a new share repurchase authorization for the repurchase of up to $500 million of the company's common stock through March 16, 2027, replacing a prior authorization which was expiring and under which there was $194.9 million remaining. The Board also declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, May 3, 2024, to shareh.

Patterson Companies Board Approves New Share Repurchase Authorization and Declares Regular Quarterly Cash Dividend

Patterson Companies, Inc. (PDCO) Q3 2024 Earnings Call Transcript

The headline numbers for Patterson Cos. (PDCO) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Patterson Cos. (PDCO) Reports Q3 Earnings: What Key Metrics Have to Say

Patterson Companies' (PDCO) third-quarter fiscal 2024 results reflect an improvement in Dental Consumable sales, offset by lower Dental Equipment sales. Animal health sales appear weak.

News for Patterson Companies Stock (PDCO)